Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 18.04
(0.33%)
HKD 18.04
(0.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.06 Billion CNY | 6.69% |
| 2022 | 8.73 Billion CNY | -1.35% |
| 2021 | 8.84 Billion CNY | 27.12% |
| 2020 | 6.96 Billion CNY | -20.96% |
| 2019 | 8.8 Billion CNY | 18.9% |
| 2018 | 7.4 Billion CNY | 24.34% |
| 2017 | 5.95 Billion CNY | 9.27% |
| 2016 | 5.45 Billion CNY | -4.54% |
| 2015 | 5.71 Billion CNY | 6.52% |
| 2014 | 5.36 Billion CNY | 10.32% |
| 2013 | 4.86 Billion CNY | 140.62% |
| 2012 | 2.02 Billion CNY | 63.52% |
| 2011 | 1.23 Billion CNY | 11.81% |
| 2010 | 1.1 Billion CNY | 8.22% |
| 2009 | 1.02 Billion CNY | -0.45% |
| 2008 | 1.02 Billion CNY | -34.45% |
| 2007 | 1.56 Billion CNY | 11.9% |
| 2006 | 1.39 Billion CNY | 12.28% |
| 2005 | 1.24 Billion CNY | 2.58% |
| 2004 | 1.21 Billion CNY | 8.23% |
| 2003 | 1.12 Billion CNY | 12.25% |
| 2002 | 999.23 Million CNY | 6.69% |
| 2001 | 936.55 Million CNY | 12.12% |
| 2000 | 835.3 Million CNY | 18.55% |
| 1999 | 704.56 Million CNY | 10.15% |
| 1998 | 639.65 Million CNY | 10.07% |
| 1997 | 581.13 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.87 Billion CNY | -7.1% |
| 2024 Q2 | 2.02 Billion CNY | -24.41% |
| 2024 Q1 | 2.68 Billion CNY | 21.25% |
| 2023 FY | 9.31 Billion CNY | 6.69% |
| 2023 Q2 | 2.21 Billion CNY | -19.0% |
| 2023 Q3 | 2.14 Billion CNY | -3.14% |
| 2023 Q1 | 2.73 Billion CNY | 27.22% |
| 2023 Q4 | 2.21 Billion CNY | 2.92% |
| 2022 Q4 | 2.15 Billion CNY | 5.36% |
| 2022 Q2 | 1.81 Billion CNY | -33.05% |
| 2022 Q1 | 2.71 Billion CNY | 31.5% |
| 2022 FY | 8.73 Billion CNY | -1.35% |
| 2022 Q3 | 2.04 Billion CNY | 12.31% |
| 2021 Q2 | 1.88 Billion CNY | -26.21% |
| 2021 Q1 | 2.55 Billion CNY | 85.16% |
| 2021 Q4 | 2.06 Billion CNY | -11.83% |
| 2021 Q3 | 2.34 Billion CNY | 24.29% |
| 2021 FY | 8.84 Billion CNY | 27.12% |
| 2020 FY | 6.96 Billion CNY | -20.96% |
| 2020 Q3 | 1.9 Billion CNY | 28.5% |
| 2020 Q4 | 1.37 Billion CNY | -27.6% |
| 2020 Q1 | 2.19 Billion CNY | 14.97% |
| 2020 Q2 | 1.48 Billion CNY | -32.34% |
| 2019 Q2 | 1.52 Billion CNY | -43.9% |
| 2019 FY | 8.8 Billion CNY | 18.9% |
| 2019 Q1 | 2.72 Billion CNY | 28.69% |
| 2019 Q3 | 2.65 Billion CNY | 73.5% |
| 2019 Q4 | 1.9 Billion CNY | -28.05% |
| 2018 Q2 | 1.46 Billion CNY | -13.28% |
| 2018 Q4 | 2.11 Billion CNY | -1.25% |
| 2018 FY | 7.4 Billion CNY | 24.34% |
| 2018 Q1 | 1.68 Billion CNY | 12.21% |
| 2018 Q3 | 2.14 Billion CNY | 46.5% |
| 2017 Q3 | 1.42 Billion CNY | 1.87% |
| 2017 FY | 5.95 Billion CNY | 9.27% |
| 2017 Q4 | 1.5 Billion CNY | 5.81% |
| 2017 Q2 | 1.39 Billion CNY | -14.95% |
| 2017 Q1 | 1.63 Billion CNY | 160.67% |
| 2016 FY | 5.45 Billion CNY | -4.54% |
| 2016 Q1 | 1.6 Billion CNY | 24.42% |
| 2016 Q2 | 1.8 Billion CNY | 12.5% |
| 2016 Q3 | 1.41 Billion CNY | -21.59% |
| 2016 Q4 | 629 Million CNY | -55.54% |
| 2015 Q2 | 1.74 Billion CNY | 37.6% |
| 2015 FY | 5.71 Billion CNY | 6.52% |
| 2015 Q1 | 1.26 Billion CNY | 18.67% |
| 2015 Q4 | 1.28 Billion CNY | -8.03% |
| 2015 Q3 | 1.4 Billion CNY | -19.74% |
| 2014 Q1 | 1.26 Billion CNY | 19.96% |
| 2014 Q3 | 1.42 Billion CNY | -10.65% |
| 2014 Q2 | 1.59 Billion CNY | 26.06% |
| 2014 FY | 5.36 Billion CNY | 10.32% |
| 2014 Q4 | 1.06 Billion CNY | -25.08% |
| 2013 FY | 4.86 Billion CNY | 140.62% |
| 2013 Q1 | 825.62 Million CNY | 7.25% |
| 2013 Q2 | 1.85 Billion CNY | 124.19% |
| 2013 Q4 | 1.05 Billion CNY | -6.3% |
| 2013 Q3 | 1.12 Billion CNY | -39.08% |
| 2012 Q3 | 555.02 Million CNY | 57.87% |
| 2012 Q1 | 343.71 Million CNY | -0.64% |
| 2012 FY | 2.02 Billion CNY | 63.52% |
| 2012 Q4 | 769.78 Million CNY | 38.69% |
| 2012 Q2 | 351.56 Million CNY | 2.29% |
| 2011 Q2 | 305.12 Million CNY | 8.95% |
| 2011 Q3 | 304.29 Million CNY | -0.27% |
| 2011 Q4 | 345.92 Million CNY | 13.68% |
| 2011 FY | 1.23 Billion CNY | 11.81% |
| 2011 Q1 | 280.05 Million CNY | -6.19% |
| 2010 Q1 | 254.37 Million CNY | -13.19% |
| 2010 Q3 | 287.18 Million CNY | 8.46% |
| 2010 FY | 1.1 Billion CNY | 8.22% |
| 2010 Q4 | 298.54 Million CNY | 3.95% |
| 2010 Q2 | 264.79 Million CNY | 4.1% |
| 2009 Q1 | 214.05 Million CNY | -13.17% |
| 2009 FY | 1.02 Billion CNY | -0.45% |
| 2009 Q4 | 293.03 Million CNY | 11.15% |
| 2009 Q3 | 263.63 Million CNY | 5.35% |
| 2009 Q2 | 250.23 Million CNY | 16.9% |
| 2008 FY | 1.02 Billion CNY | -34.45% |
| 2008 Q4 | 246.5 Million CNY | 5.7% |
| 2008 Q3 | 233.21 Million CNY | -33.72% |
| 2008 Q1 | 365.37 Million CNY | -28.82% |
| 2008 Q2 | 351.85 Million CNY | -3.7% |
| 2007 Q3 | 365.48 Million CNY | 4.34% |
| 2007 FY | 1.56 Billion CNY | 11.9% |
| 2007 Q1 | 335.49 Million CNY | 12.57% |
| 2007 Q2 | 350.27 Million CNY | 4.4% |
| 2007 Q4 | 513.27 Million CNY | 40.44% |
| 2006 Q1 | 356.57 Million CNY | 17.73% |
| 2006 Q4 | 298.03 Million CNY | -18.08% |
| 2006 FY | 1.39 Billion CNY | 12.28% |
| 2006 Q3 | 363.79 Million CNY | -4.21% |
| 2006 Q2 | 379.76 Million CNY | 6.5% |
| 2005 Q4 | 302.88 Million CNY | -1.66% |
| 2005 Q3 | 307.99 Million CNY | -3.61% |
| 2005 Q2 | 319.52 Million CNY | 1.48% |
| 2005 Q1 | 314.85 Million CNY | 6.96% |
| 2005 FY | 1.24 Billion CNY | 2.58% |
| 2004 Q3 | 296.79 Million CNY | -7.84% |
| 2004 Q1 | 300.74 Million CNY | 3.01% |
| 2004 FY | 1.21 Billion CNY | 8.23% |
| 2004 Q4 | 294.36 Million CNY | -0.82% |
| 2004 Q2 | 322.05 Million CNY | 7.08% |
| 2003 Q1 | 283.26 Million CNY | 13.52% |
| 2003 Q2 | 271.48 Million CNY | -4.16% |
| 2003 Q3 | 274.94 Million CNY | 1.27% |
| 2003 FY | 1.12 Billion CNY | 12.25% |
| 2003 Q4 | 291.95 Million CNY | 6.19% |
| 2002 Q1 | 248.33 Million CNY | 0.0% |
| 2002 Q4 | 249.52 Million CNY | -1.48% |
| 2002 Q3 | 253.26 Million CNY | 2.08% |
| 2002 Q2 | 248.11 Million CNY | -0.09% |
| 2002 FY | 999.23 Million CNY | 6.69% |
| 2001 FY | 936.55 Million CNY | 12.12% |
| 2000 FY | 835.3 Million CNY | 18.55% |
| 1999 FY | 704.56 Million CNY | 10.15% |
| 1998 FY | 639.65 Million CNY | 10.07% |
| 1997 FY | 581.13 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -37020.855% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | -134.84% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -25419.739% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -2461.614% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -52913.669% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -1434.098% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -637.727% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -1700.807% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -4085.219% |
| SSY Group Limited | 1.98 Billion HKD | -357.728% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -5432.474% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -3055.187% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 69.114% |